Randomised phase II trial of 4 dose levels of single agent docetaxel in performance status (PS) 2 patients with advanced non-small cell lung cancer (NSCLC): DOC PS2 trial. Manchester lung cancer group
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Raffaele Califano Corinne Faivre-Finn Richard Wyn Griffiths Paul Lorigan Fiona Blackhall |
| Publication date | February 5, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |